Leukemia
SOHO Brazil 2022
SOHO Brazil 2022: All You Need to Know (Until Now) About Targeted Therapy in AML. Summary of All Summaries
FEATURING
Keith Pratz,
Phillip Scheinberg
- 86 views
- August 31, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on CLL: The PI3K Inhibitors, the "Not-So-New Kid on the Block"
FEATURING
Nitin Jain,
Phillip Scheinberg
- 14 views
- August 30, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on CLL: The BTK Inhibitors That Continue to “Heat-Up” the Class
FEATURING
Nitin Jain,
Phillip Scheinberg
- 23 views
- August 30, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on Ph+ ALL: Is the Combination With TKIs Curing Patients?
FEATURING
Josep-Maria Ribera,
Phillip Scheinberg
- 47 views
- August 30, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on High-Risk AML: Is Conventional Chemo Still the Best?
FEATURING
Daniel Pollyea,
Phillip Scheinberg
- 16 views
- August 30, 2022
SOHO Brazil 2022
SOHO Brazil 2022 on CLL: Do BTKi + BCL2 Inhibitors Need a Partner?
FEATURING
Nitin Jain,
Phillip Scheinberg
- 16 views
- August 30, 2022
SOHO Brazil 2022
SOHO Brazil 2022: Can Someone Be Destined to Develop AML? Understanding Germline Mutations
FEATURING
Lucy Godley,
Phillip Scheinberg
- 31 views
- August 30, 2022
- 2